“Hepatitis b”的搜索结果,显示 661-670 项,共有 9260 项
... B cell malignancies by engineering T cells to recognize B cell specific tumor markers; however, attempts to treat solid tumors with CAR T-cells have ...
The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of ...
myelogenous leukemia, B-cell lymphoma, Diffuse large b-cell lymphoma, Aplastic anemia, T-cell lymphoma, Follicular lymphoma, Peripheral T-cell lymphoma. 显示 ...
姓氏首字母: B. 研究. 医生在讨论影像学检查结果. 妙佑医疗国际的医生和科学家 ... 按姓名字母顺序A-Z. 以下医生姓氏开头为A A · 以下医生姓氏开头为B B · 以下医生姓氏 ...
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...
Rochester, Minn. The purpose of this study is to determine whether transverse/sigmoid sinus junction stenting reduces the risk of recurrent cerebrospinal fluid ...
... B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG recommended high ...
Alyx B. Porter, M.D.. Neurologist. Phoenix, AZ ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
B · 查找姓氏以该字母开头的医生C C · 查找姓氏以该字母开头的医生D D; 未找到 ... 姓氏首字母: B. 研究. 周围神经瘤的研究人员. 妙佑医疗国际的研究人员在讨论神经鞘瘤 ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊,和我们一起进行尖端研究和医护,共同推动医学的改变。